| Patents for C07C 405 - Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins (3,702) |
|---|
| 07/22/2009 | CN101486699A Prostaglandin synthesis |
| 06/30/2009 | US7553875 to stimulate hair growth, restore hair color to depigmented hair, alopecia; side effects reduction; (16-(3-chlorophenoxy)-17,18,19,20-tetranor PGF2 alpha ) cyclopropyl amide |
| 06/30/2009 | US7553874 Prostaglandin analog compositions and methods to treat epithelial-related conditions |
| 06/25/2009 | WO2009078965A1 An improved process to prepare treprostinil, the active ingredient in remodulin® |
| 06/25/2009 | CA2710205A1 An improved process to prepare treprostinil, the active ingredient in remodulin |
| 06/23/2009 | US7550508 Prostaglandin analog compositions and methods to treat epithelial-related conditions |
| 06/17/2009 | EP1871381B1 Therapeutic substituted cyclopentanones |
| 06/17/2009 | EP1267883B1 Bile secretion promoting composition for liver transplantation containing a 15-keto-prostaglandin |
| 06/11/2009 | WO2009073432A1 Substituted cyclopentanes having prostaglandin activity |
| 06/11/2009 | CA2706879A1 Substituted cyclopentanes having prostaglandin activity |
| 06/10/2009 | CN101454281A Prostaglandin ep4 agonists |
| 06/02/2009 | US7541382 Prostaglandin analog compositions and methods to treat epithelial-related conditions |
| 05/06/2009 | EP2054540A2 Tagging reagents and methods for hydroxylated compounds |
| 04/21/2009 | CA2225761C Difluoroprostaglandin derivatives and their use |
| 04/15/2009 | EP1694641B1 Prostaglandin synthesis |
| 04/14/2009 | US7517912 to stimulate hair growth, restore hair color to depigmented hair, alopecia; side effects reduction; 17-phenyl trinor PGF2 alpha cyclopropyl methyl amide |
| 04/08/2009 | EP2043993A2 Cyclopentane derivatives as antiglaucoma agents |
| 04/07/2009 | US7514474 Prostaglandin analog compositions and methods to treat epithelial-related conditions |
| 04/02/2009 | US20090088366 Nitrosated and nitrosylated prostaglandins, compositions and methods of use |
| 03/19/2009 | WO2009035565A1 Prostaglandin analogues for implant devices and methods |
| 03/18/2009 | CN100469765C Prostaglandin nitrooxyderivatives |
| 03/04/2009 | CN101379051A Method for preparing prostaglandin derivative |
| 03/03/2009 | US7498458 Process for the preparation of prostaglandins and analogues thereof |
| 02/25/2009 | EP2027085A1 Prostaglandin ep4 agonists |
| 02/25/2009 | EP1716113B1 Ep2- receptor agonists |
| 02/11/2009 | EP2021322A2 Therapeutic cyclopentane derivatives |
| 01/29/2009 | US20090030076 Prostaglandin derivatives |
| 01/27/2009 | CA2334355C Prostaglandin derivatives |
| 01/22/2009 | US20090022787 Pharmaceutical composition comprising 11-deoxy- prostaglandin compound and method for stabilizing the compound |
| 01/20/2009 | CA2364944C C16 unsaturated fp-selective prostaglandins analogs |
| 01/08/2009 | WO2009006370A1 Therapeutic substituted cyclopentanes for reducing intraocular pressure |
| 01/08/2009 | WO2009005172A1 Pharmaceutical combination of nsaid and prostaglandin compound |
| 01/08/2009 | WO2009005171A1 Pharmaceutical combination of opioid and prostaglandin compound |
| 01/08/2009 | CA2692572A1 Therapeutic substituted cyclopentanes for reducing intraocular pressure |
| 01/08/2009 | CA2691107A1 Pharmaceutical combination of nsaid and prostaglandin compound |
| 01/08/2009 | CA2691102A1 Pharmaceutical combination of opioid and prostaglandin compound |
| 12/11/2008 | WO2007123818A3 Organic nitric oxide enhancing salts of prostaglandins, compositions and methods of use |
| 12/10/2008 | CN101318948A Lubiprostone1 crystal, preparation method and uses thereof |
| 12/04/2008 | WO2008146105A1 Prostaglandin pharmaceutical compositions |
| 12/02/2008 | US7459583 13,14-dihydro-16,16-difluoro-prostaglandin E1; cathartic inducing effect; halogenated bioactive lipid; for relieving or preventing constipation, cleansing the gastrointestinal tract; side effect reduction |
| 12/02/2008 | CA2333038C Sleep-inducing preparation |
| 11/26/2008 | CN101312946A 9-chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments |
| 11/11/2008 | US7449595 Nitrosated and nitrosylated prostaglandins, compositions and methods of use |
| 11/11/2008 | US7449469 Improved pharmacological activity and tolerability; glaucoma; ocular hypertension |
| 11/04/2008 | CA2229183C Endothelin antagonist |
| 10/29/2008 | EP1085012B1 Process for producing a purified prostaglandin derivative |
| 10/22/2008 | EP1981867A2 Method for preparing prostaglandin derivative |
| 10/02/2008 | US20080241078 Compositions and methods for treating hair loss using c16-c20 aromatic tetrahydro prostaglandins |
| 09/17/2008 | CN101265226A Compounds and methods for delivery of prostacyclin analogs |
| 08/27/2008 | EP1960353A2 Prostaglandins and analogues as agents for lowering intraocular pressure |
| 08/06/2008 | CN100408039C 止痒剂 Antipruritics |
| 08/05/2008 | US7407987 Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins |
| 07/31/2008 | WO2008091810A1 Substituted arylcylopentenes as therapeutic agents |
| 07/31/2008 | CA2675632A1 Substituted arylcyclopentenes as therapeutic agents |
| 07/10/2008 | WO2007140380A3 Tagging reagents and methods for hydroxylated compounds |
| 07/08/2008 | US7396946 Compound for treatment of external secretion disorders |
| 06/19/2008 | US20080146821 Internal 1,15-Lactones Of Fluprostenol And Related Prostaglandin F2a Analogs And Their Use In The Treatment Of Glaucoma And Intraocular Hypertension |
| 06/12/2008 | WO2007127639A3 Prodrug derivatives of acids using alcohols with homotopic hydroxy groups and methods for their preparation and use |
| 06/05/2008 | US20080132543 Therapeutic and Delivery Methods of Prostaglandin Ep4, Agonists |
| 05/14/2008 | EP1920764A1 Fluprostenol isopropyl ester for use in the treatment of glaucoma and ocular hypertension |
| 05/14/2008 | CN101180096A Method and composition for treating mucosal disorders |
| 05/07/2008 | EP1917239A1 Fluoroprostaglandins nitroderivatives |
| 04/15/2008 | US7358275 cloprostenol or latanoprost; topical use; highly crystalline structures that are easy to formulate into ophthalmic solutions; The hydrolysis of these analogs releases only the active PGF2 alpha analog free acid, without the production of toxic and irritant small aliphatic alcohol coproducts |
| 03/20/2008 | US20080070978 cloprostenol or latanoprost; topical use; highly crystalline structures that are easy to formulate into ophthalmic solutions; hydrolysis of these analogs does not have toxic and irritant small aliphatic alcohol coproducts; hypotensive agent for intraocular pressure |
| 03/19/2008 | EP1899295A2 Prostaglandin derivatives |
| 03/06/2008 | WO2007140136A3 Therapeutic cyclopentane derivatives |
| 03/06/2008 | WO2007000641A8 Prostaglandin derivatives |
| 03/06/2008 | US20080058392 Prostaglandin derivatives |
| 02/27/2008 | EP1891005A2 Process for preparation of 13,14-dihydro-pgf2 alpha derivatives |
| 02/27/2008 | EP1389116B1 Cathartic-inducing composition |
| 02/21/2008 | US20080045596 Ep2 Receptor Agonists |
| 02/13/2008 | EP1886992A1 Method for preparing prostaglandin derivative |
| 02/07/2008 | US20080033036 Composition and Method for Promoting Hair Growth |
| 01/24/2008 | WO2007091697A3 Method for preparing prostaglandin derivative |
| 01/16/2008 | CN101107225A 12-aryl prostaglandin analogs |
| 01/02/2008 | EP1871381A2 Therapeutic substituted cyclopentanones |
| 12/27/2007 | WO2007130902A3 Therapeutic cyclopentane derivatives |
| 12/12/2007 | CN101085756A Endothelin antagonist |
| 12/06/2007 | CA2667854A1 Tagging reagents and methods for hydroxylated compounds |
| 12/06/2007 | CA2652990A1 Therapeutic cyclopentane derivatives |
| 12/05/2007 | EP1861169A2 Method and composition for treating mucosal disorders |
| 12/04/2007 | US7304186 Synthetic method and novel chemical compounds |
| 11/28/2007 | EP1858592A2 Treatment of inflammatory bowel disease |
| 11/15/2007 | CA2651045A1 Therapeutic cyclopentane derivatives |
| 10/11/2007 | WO2007115001A1 Prostaglandin ep4 agonists |
| 10/11/2007 | CA2648159A1 Prostaglandin ep4 agonists |
| 09/25/2007 | US7273946 Nitroxy derivatives, e.g., 4-(nitrooxy)butyl [1R-[1 alpha (Z),2 alpha (R*),3 alpha ,5 alpha ]]-7-[3,5-dihydroxy-2-(3-hydroxy-5-phenylpentyl)cyclopentyl]-5-heptenoate; used for the treatment of glaucoma and ocular hypertension |
| 09/20/2007 | US20070219256 Cyclopentane heptan(ene)oic acid, 2-thiocarbamoyloxy and 2-carbamoyloxy compounds as therapeutic agents |
| 09/19/2007 | CN100337632C Endothelin antagonist |
| 09/11/2007 | US7268239 Process for the preparation of prostaglandins and analogues thereof |
| 08/22/2007 | EP1819670A1 12-aryl prostaglandin analogs |
| 08/16/2007 | CA2856659A1 Prostaglandin derivatives |
| 08/16/2007 | CA2819844A1 Prostaglandin derivatives |
| 08/16/2007 | CA2637797A1 Method for preparing prostaglandin derivative |
| 08/08/2007 | EP1816121A1 9-Chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments |
| 08/08/2007 | EP1814848A1 2,3,4-substituted-cyclopentanones as therapeutic agents |
| 08/07/2007 | US7253295 Chloride channel opener |
| 08/01/2007 | EP1812387A1 2,3,4-substituted cyclopentanones as therapeutic agents |
| 07/26/2007 | WO2007056087A8 Prostaglandins and analogues as agents for lowering intraocular pressure |
| 07/25/2007 | EP1810967A1 Processes and intermediates for the preparations of prostaglandins |